You are here

Article Text

Article menu
Download PDFPDF
Uterine Cancer
Role of Circulating Free Alu DNA in Endometrial Cancer
  1. Hideo Tanaka, MD, PhD*,
  2. Hiroshi Tsuda, MD, PhD*,
  3. Sadako Nishimura, MD, PhD†,
  4. Hiroyuki Nomura, MD, PhD*,
  5. Fumio Kataoka, MD*,
  6. Tatsuyuki Chiyoda, MD*,
  7. Kyoko Tanaka, MD, PhD*,
  8. Yoko Iguchi, MD, PhD*,
  9. Nobuyuki Susumu, MD, PhD* and
  10. Daisuke Aoki, MD, PhD*
  1. * Department of Obstetrics and Gynecology, School of Medicine, Keio University, Tokyo; and
  2. † Department of Obstetrics and Gynecology, Osaka City General Hospital, Osaka, Japan.
  1. Address correspondence and reprint requests to Hiroshi Tsuda, MD, PhD, Department of Obstetrics and Gynecology, School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan. E-mail: htsud{at}sc.itc.keio.ac.jp.

Abstract

Conclusions Measurement of cell-free DNA is not useful for EC screening; however, the change of cell-free DNA in a patient may be a prognostic biomarker of EC.

  • Endometrial cancer
  • Screening
  • Serum biomarker

https://doi.org/10.1097/IGC.0b013e3182328c94

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • The authors have no conflicts of interest.